相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects
Jerold Chun et al.
DRUGS (2021)
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod
Maria Eleftheria Evangelopoulos et al.
CNS NEUROSCIENCE & THERAPEUTICS (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation
Maria Teresa Giordana et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation
Maria Teresa Giordana et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Severe disease exacerbations in patients with multiple sclerosis after discontinuing fingolimod
Anna Czlonkowska et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2017)
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
Burhan Z. Chaudhry et al.
NEUROTHERAPEUTICS (2017)
Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis
Tuncay Gunduz et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
Stacy Ellen Hatcher et al.
JAMA NEUROLOGY (2016)
Bitopic Sphingosine 1-Phosphate Receptor 3 (S1P3) Antagonist Rescue from Complete Heart Block: Pharmacological and Genetic Evidence for Direct S1P3 Regulation of Mouse Cardiac Conduction
M. Germana Sanna et al.
MOLECULAR PHARMACOLOGY (2016)
Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingorimod MS rebound
Leonardo Cavone et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Fingolimod May Support Neuroprotection via Blockade of Astrocyte Nitric Oxide
Emanuela Colombo et al.
ANNALS OF NEUROLOGY (2014)
Sphingosine 1-Phosphate Receptor 1 and 3 Are Upregulated in Multiple Sclerosis Lesions
Ruben Van Doorn et al.
GLIA (2010)
On the rate and extent of drug delivery to the brain
Margareta Hammarlund-Udenaes et al.
PHARMACEUTICAL RESEARCH (2008)
分享论文
